Bank of Montreal Can lowered its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 51,324 shares of the company’s stock after selling 533 shares during the period. Bank of Montreal Can’s holdings in Acadia Healthcare were worth $2,535,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. boosted its stake in Acadia Healthcare by 43.9% in the first quarter. Russell Investments Group Ltd. now owns 221,649 shares of the company’s stock worth $9,664,000 after buying an additional 67,665 shares during the period. Emerald Advisers Inc. PA boosted its stake in Acadia Healthcare by 2.3% in the first quarter. Emerald Advisers Inc. PA now owns 85,198 shares of the company’s stock worth $3,715,000 after buying an additional 1,876 shares during the period. Parametrica Management Ltd purchased a new stake in Acadia Healthcare during the first quarter worth about $291,000. UBS Asset Management Americas Inc. boosted its stake in Acadia Healthcare by 21.6% in the first quarter. UBS Asset Management Americas Inc. now owns 332,355 shares of the company’s stock worth $14,491,000 after buying an additional 59,001 shares during the period. Finally, Vanguard Group Inc. boosted its stake in Acadia Healthcare by 8.1% in the first quarter. Vanguard Group Inc. now owns 5,743,233 shares of the company’s stock worth $250,404,000 after buying an additional 431,550 shares during the period.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) traded down 0.89% on Thursday, reaching $51.04. 236,547 shares of the company traded hands. The stock has a 50-day moving average price of $50.00 and a 200-day moving average price of $44.52. The firm has a market cap of $4.48 billion, a P/E ratio of 560.88 and a beta of 1.15. Acadia Healthcare Company, Inc. has a 52-week low of $32.54 and a 52-week high of $54.73.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The firm had revenue of $715.90 million during the quarter, compared to analysts’ expectations of $717.38 million. During the same period in the prior year, the company posted $0.73 EPS. The company’s revenue was down 5.4% on a year-over-year basis. Analysts anticipate that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Position Cut by Bank of Montreal Can” was reported by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.dailypolitical.com/2017/08/10/acadia-healthcare-company-inc-nasdaqachc-position-cut-by-bank-of-montreal-can.html.

A number of equities research analysts have issued reports on ACHC shares. William Blair started coverage on shares of Acadia Healthcare in a report on Tuesday, July 18th. They set an “outperform” rating for the company. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Friday, April 28th. Jefferies Group LLC set a $55.00 price target on shares of Acadia Healthcare and gave the company a “buy” rating in a report on Thursday, June 1st. Leerink Swann cut shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating in a report on Monday, May 15th. Finally, BidaskClub upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 1st. Five research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. Acadia Healthcare presently has an average rating of “Buy” and a consensus target price of $59.21.

In other Acadia Healthcare news, Director William Grieco sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $45.42, for a total value of $90,840.00. Following the completion of the transaction, the director now directly owns 47,013 shares in the company, valued at approximately $2,135,330.46. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Reeve B. Waud sold 50,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $45.09, for a total transaction of $2,254,500.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 2,136,347 shares of company stock valued at $105,383,249. Corporate insiders own 11.10% of the company’s stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.